CVE:LTV Leonovus (LTV) Stock Forecast, Price & News C$0.02 -0.01 (-20.00%) (As of 09/20/2023 05:20 PM ET) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0352-Week RangeC$0.02▼C$0.08Volume7,000 shsAverage Volume26,749 shsMarket CapitalizationC$418,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Leonovus (CVE:LTV) StockLeonovus Inc. operates as a data management software company. Its tools offer data-centric solutions to customers. The company is based in Ottawa, Canada.Read More LTV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTV Stock News HeadlinesSeptember 14, 2023 | forbes.comMortgage News: Nationwide Leads Latest Wave Of Cuts To Fixed-Rate DealsJuly 8, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc up on Thursday (LTV)September 21, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.June 22, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc down on Tuesday (LTV)June 10, 2023 | forbes.comMortgage News: HSBC, Clydesdale Join Ranks Of Lenders Adjusting Product OffersJune 5, 2023 | finance.yahoo.comNewRange Initiates Salvage and Recycle Project at Former LTV Steel SiteMay 17, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc up on Tuesday (LTV)May 10, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc up on Monday (LTV)September 21, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 3, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc flat on Monday (LTV)May 1, 2023 | finance.yahoo.comLeonovus Announces Releases 2022 Audit Results, Announces New CFO and Business UpdateApril 24, 2023 | finance.yahoo.comLeonovus Announces Change of AuditorApril 21, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc flat on Thursday (LTV)April 15, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc flat on Friday (LTV)April 13, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc flat on Tuesday (LTV)April 11, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc down on Monday (LTV)April 9, 2023 | finance.yahoo.comLeonovus Inc. (LTV.V)April 6, 2023 | theglobeandmail.comClosing Bell: Leonovus Inc flat on Wednesday (LTV)February 3, 2023 | yahoo.comLeonovus Announces Bridge LoanJanuary 7, 2023 | nz.finance.yahoo.comLeonovus Announces the Retirement of Part-Time CFOSeptember 10, 2022 | theglobeandmail.comLeoNovus: Top 10 Undervalued Software Industry Sector Stocks on TSX Venture Exchange (LTV)September 9, 2022 | theglobeandmail.comLeoNovus: Top 10 Undervalued Technology Stocks on TSX Venture Exchange (LTV)August 31, 2022 | yahoo.comWhat a Rugby Tournament Says About Hong Kong’s Fate as a Financial CenterAugust 30, 2022 | yahoo.comEastEnders boss shares dramatic arrival for Freddie SlaterAugust 30, 2022 | nz.finance.yahoo.comBlack, Hispanic And Asian Babies Born Very Early Are Less Likely To Receive Lifesaving MeasuresAugust 30, 2022 | reuters.comLTV.V - LeoNovus Inc | Stock Price & Latest News | ReutersAugust 29, 2022 | nz.finance.yahoo.comLeonovus Inc. Files Q2 2022 Financial ResultsSee More Headlines Receive LTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Leonovus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Software—Application Sub-IndustryN/A SectorComputer and Technology Current SymbolCVE:LTV CUSIPN/A CIKN/A Webwww.leonovus.com Phone+1-408-5419400FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-1,500,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-227.68% Return on Assets-75.24% Debt Debt-to-Equity Ratio301.95 Current Ratio0.05 Quick Ratio0.09 Sales & Book Value Annual SalesC$5,000.00 Price / Sales83.60 Cash FlowC$0.00 per share Price / Cash Flow25.00 Book ValueC($0.05) per share Price / Book-0.40Miscellaneous Outstanding Shares20,900,000Free FloatN/AMarket CapC$418,000.00 OptionableNot Optionable Beta0.38 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Michael J. Gaffney B.Sc. (Age 69)CHRP, M.B.A., Chairman & CEO Comp: $145.09kMr. Daniel Willis (Age 62)Exec. Advisor, CTO & Director Comp: $206.03kMr. Chris CarmichaelChief Financial OfficerKey CompetitorsHunter TechnologyCVE:HOCMemexCVE:OEEIdentillect TechnologiesCVE:IDRoute1CVE:ROIDeepMarkitCVE:MKTView All Competitors LTV Stock - Frequently Asked Questions How have LTV shares performed in 2023? Leonovus' stock was trading at C$0.04 on January 1st, 2023. Since then, LTV shares have decreased by 50.0% and is now trading at C$0.02. View the best growth stocks for 2023 here. What other stocks do shareholders of Leonovus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Leonovus investors own include Journey Energy (JOY), Medical Facilities (DR), Alimentation Couche-Tard (ATD.B), Aurora Cannabis (ACB), Big Tree Group (BIGG), CRH Medical (CRH), DHX Media (DHX.B), CGI (GIB), HIVE Digital Technologies (HIVE) and Inovio Pharmaceuticals (INO). What is Leonovus' stock symbol? Leonovus trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTV." How do I buy shares of Leonovus? Shares of LTV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Leonovus' stock price today? One share of LTV stock can currently be purchased for approximately C$0.02. How much money does Leonovus make? Leonovus (CVE:LTV) has a market capitalization of C$418,000.00 and generates C$5,000.00 in revenue each year. The company earns C$-1,500,000.00 in net income (profit) each year or C($0.07) on an earnings per share basis. How can I contact Leonovus? Leonovus' mailing address is 1400-340 Albert St, OTTAWA, ON K1R 0A5, Canada. The official website for the company is www.leonovus.com. The company can be reached via phone at +1-408-5419400. This page (CVE:LTV) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leonovus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.